Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study

BACKGROUND: Atherosclerosis is a chronic inflammatory disease, with interleukin 6 (IL‐6) as a major player in inflammation cascade. IL‐6 blockade may reduce cardiovascular risk, but current treatments to block IL‐6 also induce dyslipidemia, a finding with an uncertain prognosis. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacchiega, Bruno Cesar, Bacchiega, Ana Beatriz, Usnayo, Magali Justina Gomez, Bedirian, Ricardo, Singh, Gurkirpal, Pinheiro, Geraldo da Rocha Castelar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524026/
https://www.ncbi.nlm.nih.gov/pubmed/28288972
http://dx.doi.org/10.1161/JAHA.116.005038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524026/
https://www.ncbi.nlm.nih.gov/pubmed/28288972
http://dx.doi.org/10.1161/JAHA.116.005038

Ejemplares similares